Keyphrases
Asthma
100%
Corticosteroids
100%
Montelukast
100%
Inflammatory Markers
100%
Lung Function
57%
Puffing
42%
Placebo
28%
Adenosine Monophosphate
28%
Parts per Billion
28%
Confidence Interval
14%
Geometric Mean
14%
Threshold Recovery
14%
Blood Eosinophils
14%
Salmeterol
14%
Fluticasone Propionate
14%
Recovery Time
14%
Clinical Benefit
14%
Threshold Time
14%
SM-1
14%
Exhaled Nitric Oxide
14%
Randomized Crossover
14%
Twice Daily
14%
Placebo-controlled Study
14%
Mild-to-moderate Asthma
14%
Additive Effect
14%
Medicine and Dentistry
Patient with Asthma
100%
Montelukast
100%
Lung
57%
Adenosine Phosphate
28%
Placebo
28%
Asthma
14%
Placebo-Controlled Study
14%
Salmeterol
14%
Eosinophil
14%
Fluticasone
14%
Nitric Oxide
14%
Pharmacology, Toxicology and Pharmaceutical Science
Montelukast
100%
Asthma
100%
Adenosine Phosphate
28%
Placebo
28%
Salmeterol
14%
Nitric Oxide
14%
Fluticasone
14%
Placebo-Controlled Study
14%
Immunology and Microbiology
Asthma
100%
Montelukast
100%
Exhaled Nitric Oxide
14%
Eosinophil Granulocyte
14%
Fluticasone/Salmeterol
14%